DNDi Best Science for the Most Neglected: Where Do We Stand 10 Years On?

DNDi Best Science for the Most Neglected: Where Do We Stand 10 Years On?

05-12-2013 - 05-12-2013 Institut Pasteur, Paris, France

Join DNDi and its founding partner, Institut Pasteur, for a special scientific event.

Join DNDi and its founding partner, Institut Pasteur, for a special scientific event culminating DNDi’s 10-year anniversary. Participants and speakers will include key actors in the field of research and development for neglected diseases, including international scientists, product developers, policy-makers, and civil society organizations. The event will explore the scientific aspects of the past decade of innovation for neglected diseases carried out by various innovative initiatives, including DNDi.

Key session themes include:

  • 10 Years of Portfolio Building for Neglected Diseases: A PDP Experience
  • Main Progress and Key Challenges in Drug Discovery for Infectious Diseases over the Past Decade
  • Breakthroughs and Challenges in Clinical Development
  • The Future of Research for Neglected Diseases

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Summit

Summit.jpg

UK drug discovery firm Summit Pharmaceuticals is an Oxford-based drug discovery and development company targeting high-value areas of unmet medical need including Duchenne Muscular Dystrophy and C. difficile infection.

Back to top